PLUS THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
PLUS THERAPEUTICS, INC. has filed 1,451 SEC EDGAR filings since 30 Mar 2001

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page
25
Current page
16
8-K File 001-34375

8-K WARRANT AMENDMENT AUGUST 2020

Filing date
04 Aug 2020
Reporting date
30 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jul 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-239548

S-8

Filing date
30 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
17 Jun 2020
Reporting date
16 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
11 Jun 2020
Reporting date
08 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 000-32501

25-NSE filing

Filing date
26 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-367505

D filing

Filing date
22 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K

Filing date
14 May 2020
Reporting date
14 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34375

Q1 2020 10-Q

Filing date
14 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
SC 13G File 005-80327

SC 13G

Filing date
14 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34375

DEF 14A

Filing date
13 May 2020
Reporting date
16 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K NANOTX

Filing date
11 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34375

PRE 14A

Filing date
01 May 2020
Reporting date
01 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-34375

10-K/A

Filing date
29 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K WARRANT AMENDMENT

Filing date
23 Apr 2020
Reporting date
17 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Apr 2020
Reporting date
01 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Apr 2020
Reporting date
01 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

8-K Q4 19 EARNINGS RELEASE

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

NANOTX OXFORD

Filing date
30 Mar 2020
Reporting date
29 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .